We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
+11.29%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$1.06B
AUM Growth
+$40.2M
(+3.9%)
Cap. Flow
-$31.9M
Cap. Flow
% of AUM
-3%
Top 10 Holdings %
Top 10 Hldgs %
38.82%
Holding
432
New
78
Increased
76
Reduced
169
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Diamondback Energy
FANG
|
+$61.4M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$26.6M |
| 3 |
Ovintiv
OVV
|
+$10M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$5.48M |
| 5 |
CHX
ChampionX
CHX
|
+$3.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DEN
Denbury Inc.
DEN
|
+$25.7M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$17.9M |
| 3 |
Antero Resources
AR
|
+$13.6M |
| 4 |
Accenture
ACN
|
+$10.7M |
| 5 |
Home Depot
HD
|
+$8.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 37.03% |
| 2 | Healthcare | 10.56% |
| 3 | Technology | 9.98% |
| 4 | Financials | 9.12% |
| 5 | Consumer Discretionary | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Cytokinetics
CYTK
$11B
| – | – |
-24,808
| Closed | -$1.2M |
|
377
Designer Brands
DBI
$277M
| – | – |
-18,833
| Closed | -$288K |
|
378
Ginkgo Bioworks
DNA
$481M
| – | – |
-5,729
| Closed | -$715K |
|
379
Duolingo
DUOL
$5.7B
| – | – |
-17,436
| Closed | -$1.66M |
|
380
Enovix
ENVX
$862M
| – | – |
-23,080
| Closed | -$370K |
|
381
Flowers Foods
FLO
$1.64B
| – | – |
-18,577
| Closed | -$459K |
|
382
H&R Block
HRB
$5.18B
| – | – |
-4,839
| Closed | -$206K |
|
383
InnovAge Holding
INNV
$1.57B
| – | – |
-34,577
| Closed | -$203K |
|
384
iRadimed
IRMD
$1.21B
| – | – |
-9,498
| Closed | -$285K |
|
385
iShares Micro-Cap ETF
IWC
$1.43B
| – | – |
-5,346
| Closed | -$552K |
|
|
NXDR
386
Nextdoor Holdings
NXDR
$835M
| – | – |
-218,313
| Closed | -$609K |
|
387
Kornit Digital
KRNT
$706M
| – | – |
-18,263
| Closed | -$486K |
|
388
Stride
LRN
$3.69B
| – | – |
-42,258
| Closed | -$1.78M |
|
389
Lulu's Fashion Lounge
LVLU
$55M
| – | – |
-1,074
| Closed | -$75K |
|
390
Mattel
MAT
$4.17B
| – | – |
-15,938
| Closed | -$302K |
|
391
Mirion Technologies
MIR
$4.05B
| – | – |
-229,105
| Closed | -$1.71M |
|
392
monday.com
MNDY
$3.27B
| – | – |
-1,835
| Closed | -$208K |
|
393
Moog Inc Class A
MOG.A
$13B
| – | – |
-6,946
| Closed | -$489K |
|
394
Marvell Technology
MRVL
$174B
| – | – |
-5,597
| Closed | -$240K |
|
395
Payoneer
PAYO
$2.41B
| – | – |
-105,805
| Closed | -$640K |
|
396
Precigen
PGEN
$1.93B
| – | – |
-45,382
| Closed | -$97K |
|
397
RB Global
RBA
$20.8B
| – | – |
-3,790
| Closed | -$237K |
|
398
Relmada Therapeutics
RLMD
$544M
| – | – |
-9,647
| Closed | -$357K |
|
399
Recursion Pharmaceuticals
RXRX
$1.57B
| – | – |
-96,803
| Closed | -$1.03M |
|
400
Sweetgreen
SG
$713M
| – | – |
-64,720
| Closed | -$1.2M |
|
Similar funds
VFG
SLG
KCP
UAG
PS
CICI
RPAM
BBI
Advisory Research's Q4 2022 Portfolio in Review
As of Q4 2022, Advisory Research held 432 positions worth $1.06B, up 3.9% from $1.02B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Advisory Research withdrew a net $31.9M in Q4 2022, closing 68 positions and reducing 169 holdings. Its most notable exit was IAA, Inc. Common Stock, an estimated $6.06M position sold in full.
By sector, the portfolio is most concentrated in Energy at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Advisory Research opened a new position in iShares Russell 2000 ETF worth $5.37M.
- Advisory Research's largest Q4 2022 buy was iShares Russell 2000 ETF: 30,811 shares worth $5.37M.
- Advisory Research added most to Diamondback Energy in Q4 2022, an estimated $61.4M increase.
- Advisory Research's biggest Q4 2022 reduction was Denbury Inc., cutting an estimated $25.7M.
- Advisory Research fully exited IAA, Inc. Common Stock in Q4 2022, selling an estimated $6.06M.
- Advisory Research's ten largest holdings make up 39% of its $1.06B portfolio in Q4 2022.
- Advisory Research opened 78 new positions and closed 68 in Q4 2022.
- Advisory Research's portfolio value rose 3.9% quarter-over-quarter to $1.06B.
Based on Advisory Research's 13F filing for Q4 2022, filed 13 Feb 2023.